Werge et al., Cloning and intracellular expression of a monoclonal antibody to the p21ras Protein, FEBS 274(1,2):193-198 (1990). |
Piccioli et al., Neuroantibodies: Molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system, Proc. Natl. Acad. Sci. 88:5611-5615 (1991). |
Biocca et al., Expression and targeting of intracellular antibodies in mammalian cells, EMBO Journal 9(1): 101-108 (1990). |
Huston et al., Protein engineering of antibody binding sites: Recovery of specific activity in an anti-diogoxin single-chain Fv analogue produced in Excherichia coli, Proc. Natl. Acad. Sci. USA 85:5879-5883 (1988). |
Biooca et al., Intracellular Expression of Anti-p21ras Single Chain Fragments Inhibits Melotic Maturation of Xenopus Oocytes, Biochemical & Biophysical Research Commun. 197(2): 422-427 (1993). |
Chaudhary et al., Pdeudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity, Proc. Natl. Acad. Sci. USA 87: 308-312 (1990). |
Benvenisty et al., Direct introduction of genes into rats and expression of the genes, Proc. Natl. Acad. Sci. USA 83: 9551-9555 (1986). |
Wang et al., pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse, Proc. Natl. Acad. Sci. USA 84:7851-7855 (1987). |
Nicolau et al., In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I, Proc. Natl. Acad. Sci. USA 80:1068-1072 (1983). |
Trono et al., HIV-1 Gag Mutants Can Dominantly Interfere with the Replication of the Wild-Type Virus, Cell 59: 113-120 (1989). |
Sullenger et al., Overexpression of TAR Sequences Renders Cells Resistant to Human Immunodeficiency Virus Replication, Cell 63: 601-608 (1990). |
Munro et al., A C-Terminal Signal Prevents Secretion of Luminal ER Proteins, Cell 48: 899-907 (1987). |
Malim et al., Functional Dissection of the HIV-1 Rev Trans-Activator-Derivation of a Trans-Dominant Repressor of Rev Function, Cell 58:205-214 (1989). |
Posner et al., An IgG Human Monoclonal Antibody That Reacts with HIV-1/GP120, Inhibits Virus Binding To Cells, and Neutralizes Infection, The Journal Immunology 146(12):4325-4332 (1991). |
Buonocore et al., Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum, Nature 345:625-628 (1990). |
Haseloff et al., Simple RNA enzymes with new and highly specific endoribonuclease activities, Nature 334:585-591 (1988). |
Rosenberg et al., Gene Transfer Into Humans-Immunotherapy of Patients With Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified By Retroviral Gene Transduction, The New England Journal of Medicine 323: 570-578 (1990). |
Riechmann et al., Expression of an Antibody Fv Fragment in Myeloma Cells, J. Mol. Biol. 203: 825-828 (1988). |
Carlson, A New Means of Inducibly Inactivating a Cellular Protein, Molecular & Cellular Biology 8(6): 2638-2646 (1988). |
Poznansky et al., Gene Transfer into Human Lymphocytes by a Defective Human Immunodeficiency Virus Type 1 Vector, Journal of Virology 65(1): 532-536 (1991). |
Faraji-Shadan et al., A Putative Approach for Gene Therapy Against Human Immunodeficiency Virus (HIV), Medical Hypotheses 32: 81-84 (1990). |
Brake et al., Characterization of Murine Monoclonal Antibodies to the tat Protein from Human Immunodeficiency Virus Type 1, Journal of Virology 64(2): 962-965 (1990). |
Kaneda et al., Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver, Science 243: 375-378 (1989). |
Anderson, Prospects for Human Gene Therapy, Science 226: 401-409 (1984). |
Selden et al., Implantation of Genetically Engineered Fibroblasts into Mice: Implications for Gene Therapy, Science 236: 714-718 (1987). |
Sarver et al., Ribozymes as Potential Anti-HIV-1 Therapeutic Agents, Science 247: 1222-1225 (1990). |
Baltimore, Intracellular Immunization, Nature 335:395-396 (1988). |
Felgner et al., Gene Therapeutics, Nature 349: 351-354 (1991). |
Seetharam et al., Increased Cytotoxic Activity of Pseudomonas Exotoxin and Two Chimeric Toxins Ending in KDEL, The Journal of Biological Chemistry 266(26): 17376-17381 (1991). |
Wu et al., Receptor-mediated Gene Delivery and Expression in Vivo, The Journal of Biological Chemistry 263(29): 14621-14624 (1988). |
Schultz et al., Hydroxylamine-Stable Covalent Linkage of Myristic Acid in Goa, A Guanine Nucleotide-Binding Protein of Bovine Brain, Biochemical & Biophysical Rsch. Commn. 146(3): 1234-1239 (1987). |
Siomi et al., Sequence Requirements for Nucleolar Localization of Human T Cell Leukemia Virus Type I pX protein, Which Regulates Viral RNA Processing, Cell 55:197-209 (1988). |
Spence et al., Affinity Purification and Characterization of Anti-Tac(Fv)-C3-PE38KDEL: A Highly Potent Cytotoxic Agent Specific to Cells Bearing IL-2 Receptors, Bioconjugate Chem. 4:63-68 (1993). |
Kreitman et al., Single-Chain Immunotoxin Fusions between Anti-Tac and Pseudomonas Exotoxin: Relative Importance of the Two Toxin Disulfide Bonds, Bioconjugate Chem. 4: 112-120 (1993). |
Norley et al., Vaccination against HIV, Immunobion 184: 193-207 (1992). |
van der Krol et al., Modulation of Eukaryotic Gene Expression by Complementary RNA or DNA Sequences, BioTechniques 6(10: 958-976 (1988). |
Russell et al., Retroviral Vectors Displaying Functional Antibody Fragments, Nucleic Acids Research, 21:5, 1081-1085 (1993). |
Rodwell, Engineering Monoclonal Antibodies, Nature, 342:6245, 99-100, (1989). |
Liu et al., Cancer Research, vol. 54, pp. 3662-3667, Jul. 15, 1994. |
Clayman et al., Cancer Research, vol. 55, pp. 1-6, Jan. 1, 1995. |
Clayman et al., Arch. Otolaryngol. Head Neck Surg., vol. 122, pp. 489-493, May. 1996. |
Clayman et al., Journal of Clinical Oncology, vol. 16, pp. 2221-2232, Jun. 1998. |
El-Naggar etal., Society for Biological Therapy: Annual Meeting, Sep. 1996. |
Orkin et al., "Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy.", Dec. 7, 1995. |
Eck and Wilson, Goodman & Gilman's The Pharmacological Basis of Therapeutics, "Gene-Based Therapy", Ninth Edition: McGraw-Hill, chapter 5, pp. 77-101, 1995. |
Hanania et al., American Journal of Medicine, vol. 99, pp. 537-552, Nov. 1995. |
Cochet et al., Cancer Research, vol. 58, pp. 1170-1176, 1998. |
Richardson et al., Trends in Biotechnology, vol. 13, pp. 306-310, 1995. |
Shirasawa et al., Science, vol. 260, pp. 85-88, Abstract only, Apr. 2, 1993. |
Levrero et al (1991) Gene 101:195-202. |
Orlandi et al (1989) Proc. Natl. Acad. Sci. USA 86:3833-3837. |
Furth et al (1982) J. Virol. 43:294-304. |
Gazitt et al (1992) J. Immunological Methods 148:159-169. |
Milner et al (1986) Virology 154:21-30. |
Duchesne et al (1993) Science 259:525-528. |
Marshall, E (1995) Science 269:1050-1055. |
Miller et al (1995) FASEB J 9:190-199. |
Crystal, R.G (1995) Science 270:404-410. |